Assessment of circulating N-terminal pro B-type natriuretic peptide concentration to differentiate between cardiac from noncardiac causes of pleural effusion in cats

    loading  Checking for direct PDF access through Ovid

Abstract

Objective

To determine the diagnostic ability of blood N-terminal pro B-type natriuretic peptide (NT-proBNP) measurement to differentiate between congestive heart failure (CHF) and noncardiogenic causes for moderate to severe pleural effusion in cats.

Design

Prospective observational study.

Setting

University teaching hospital.

Animals

Twenty-one cats with moderate to severe pleural effusion.

Interventions

Venous blood sampling for NT-proBNP measurement.

Measurement and Results

According to the results of echocardiographic examination, cats were classified in a group with CHF (n = 11) or noncongestive heart failure (N-CHF, n = 10). NT-proBNP was measured via a feline-specific test in EDTA plasma with protease inhibitor. NT-proBNP was significantly (P < 0.0001) higher in the CHF group ( median 982 pmol/L, 355–1,286 pmol/L) than in the N-CHF group (median 69 pmol/L, 26 – 160 pmol/L) and discriminated exactly (area under the curve = 1.0, 95% confidence interval 1.0–1.0) between both groups. Optimum cut-off value considering all samples was 258 pmol/L.

Conclusion

In this small population of cats with pleural effusion, NT-proBNP was able to differentiate between cats with cardiogenic and noncardiogenic causes of effusion. With the currently recommended method of measurement (ie, EDTA plasma with protease inhibitor), a cut-off value of 258 pmol/L discriminates effectively between cats with and without CHF.

Related Topics

    loading  Loading Related Articles